Clinical Trials Directory

Trials / Unknown

UnknownNCT01750385

Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Peroral Endoscopic Myotomy (POEM) is a novel, promising endoscopic technique for achalasia because it is safer and more effective than traditional Heller's myotomy. However, the issue of antibiotic prophylaxis in POEM has evoked considerable controversy recently. Therefore, we conduct this study to elucidate the status of POEM-related bacteremia and procalcitonin levels in order to preliminary observe whether antibiotic prophylaxis is needed.

Detailed description

Objective: To elucidate the status of POEM-related bacteremia and procalcitonin levels in order to preliminary observe whether antibiotic prophylaxis is needed. Interventions: Patients with achalasia diagnosed by symptoms, endoscopy and barium swallow eligible for POEM are randomized to either use antibiotic prophylactically or not. Main outcome measurements: Blood culture positive incidence; secondary outcomes are procalcitonin levels, C-reactive protein levels, white blood cell counts and so on.

Conditions

Interventions

TypeNameDescription
DRUGno antibiotic prophylaxisThese patients are in no antibiotic prophylaxis group will not be administered antibiotic prophylactically.
DRUGsecond-generation cephalosporinThese patients are in antibiotic prophylaxis group will be administered second-generation cephalosporin prophylactically.

Timeline

Start date
2012-10-01
Primary completion
2013-04-01
Completion
2013-08-01
First posted
2012-12-17
Last updated
2012-12-17

Source: ClinicalTrials.gov record NCT01750385. Inclusion in this directory is not an endorsement.